Bionano Genomics, Inc. (BNGO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Bionano Genomics, Inc. (BNGO) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $4.1M, listed on NASDAQ, employing roughly 98 people, carrying a beta of 1.65 to the broader market. Bionano Genomics, Inc. Led by Robert Erik Holmlin, public since 2018-08-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for BNGO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →